Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 944Neoplasms 713Prostatic Neoplasms 498Lung Neoplasms 402Colorectal Neoplasms 363Carcinoma, Non-Small-Cell Lung 362Leukemia, Myeloid, Acute 290Pancreatic Neoplasms 239Brain Neoplasms 230Neoplasm Metastasis 225Multiple Myeloma 218Carcinoma, Hepatocellular 202Head and Neck Neoplasms 187Glioblastoma 183Precursor Cell Lymphoblastic Leukemia-Lymphoma 181Melanoma 177Ovarian Neoplasms 170Squamous Cell Carcinoma of Head and Neck 161Rectal Neoplasms 145Uterine Cervical Neoplasms 144Recurrence 143Hematologic Neoplasms 137Sarcoma 136Glioma 132Stomach Neoplasms 129Triple Negative Breast Neoplasms 127Carcinoma, Renal Cell 126Myelodysplastic Syndromes 114Colonic Neoplasms 113Esophageal Neoplasms 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hernia, Ventral × 90 days × Clear all
NCT07451483 2026-03-05

Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.

Jules Bordet Institute

Recruiting
500 enrolled
GastrointestinalGynecologic

Hernia, Ventral, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡